HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $82.72 billion. The enterprise value is $125.94 billion.
Market Cap | 82.72B |
Enterprise Value | 125.94B |
Important Dates
The next confirmed earnings date is Friday, April 25, 2025, before market open.
Earnings Date | Apr 25, 2025 |
Ex-Dividend Date | Mar 17, 2025 |
Share Statistics
HCA Healthcare has 246.20 million shares outstanding. The number of shares has decreased by -5.28% in one year.
Current Share Class | 246.20M |
Shares Outstanding | 246.20M |
Shares Change (YoY) | -5.28% |
Shares Change (QoQ) | -1.77% |
Owned by Insiders (%) | 1.34% |
Owned by Institutions (%) | 66.33% |
Float | 173.76M |
Valuation Ratios
The trailing PE ratio is 15.27 and the forward PE ratio is 13.46. HCA Healthcare's PEG ratio is 1.10.
PE Ratio | 15.27 |
Forward PE | 13.46 |
PS Ratio | 1.23 |
Forward PS | 1.10 |
PB Ratio | 149.04 |
P/TBV Ratio | n/a |
P/FCF Ratio | 14.67 |
P/OCF Ratio | 7.87 |
PEG Ratio | 1.10 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.09, with an EV/FCF ratio of 22.33.
EV / Earnings | 21.86 |
EV / Sales | 1.78 |
EV / EBITDA | 9.09 |
EV / EBIT | 11.94 |
EV / FCF | 22.33 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 81.51.
Current Ratio | 1.08 |
Quick Ratio | 0.84 |
Debt / Equity | 81.51 |
Debt / EBITDA | 3.03 |
Debt / FCF | 8.02 |
Interest Coverage | 5.12 |
Financial Efficiency
Return on equity (ROE) is 824.40% and return on invested capital (ROIC) is 14.86%.
Return on Equity (ROE) | 824.40% |
Return on Assets (ROA) | 11.39% |
Return on Invested Capital (ROIC) | 14.86% |
Return on Capital Employed (ROCE) | 23.79% |
Revenue Per Employee | $223,427 |
Profits Per Employee | $18,228 |
Employee Count | 316,000 |
Asset Turnover | 1.22 |
Inventory Turnover | 22.31 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.87 billion in taxes.
Income Tax | 1.87B |
Effective Tax Rate | 21.89% |
Stock Price Statistics
The stock price has increased by +8.27% in the last 52 weeks. The beta is 1.49, so HCA Healthcare's price volatility has been higher than the market average.
Beta (5Y) | 1.49 |
52-Week Price Change | +8.27% |
50-Day Moving Average | 328.13 |
200-Day Moving Average | 345.89 |
Relative Strength Index (RSI) | 52.35 |
Average Volume (20 Days) | 1,630,872 |
Short Selling Information
The latest short interest is 5.58 million, so 2.26% of the outstanding shares have been sold short.
Short Interest | 5.58M |
Short Previous Month | 5.89M |
Short % of Shares Out | 2.26% |
Short % of Float | 3.21% |
Short Ratio (days to cover) | 3.45 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $70.60 billion and earned $5.76 billion in profits. Earnings per share was $22.00.
Revenue | 70.60B |
Gross Profit | 28.68B |
Operating Income | 10.55B |
Pretax Income | 7.57B |
Net Income | 5.76B |
EBITDA | 13.86B |
EBIT | 10.55B |
Earnings Per Share (EPS) | $22.00 |
Balance Sheet
The company has $2.02 billion in cash and $45.24 billion in debt, giving a net cash position of -$43.22 billion or -$175.53 per share.
Cash & Cash Equivalents | 2.02B |
Total Debt | 45.24B |
Net Cash | -43.22B |
Net Cash Per Share | -$175.53 |
Equity (Book Value) | 555.00M |
Book Value Per Share | -10.00 |
Working Capital | 1.24B |
Cash Flow
In the last 12 months, operating cash flow was $10.51 billion and capital expenditures -$4.88 billion, giving a free cash flow of $5.64 billion.
Operating Cash Flow | 10.51B |
Capital Expenditures | -4.88B |
Free Cash Flow | 5.64B |
FCF Per Share | $22.90 |
Margins
Gross margin is 40.62%, with operating and profit margins of 14.94% and 8.16%.
Gross Margin | 40.62% |
Operating Margin | 14.94% |
Pretax Margin | 12.07% |
Profit Margin | 8.16% |
EBITDA Margin | 19.63% |
EBIT Margin | 14.94% |
FCF Margin | 7.99% |
Dividends & Yields
This stock pays an annual dividend of $2.88, which amounts to a dividend yield of 0.86%.
Dividend Per Share | $2.88 |
Dividend Yield | 0.86% |
Dividend Growth (YoY) | 9.76% |
Years of Dividend Growth | 4 |
Payout Ratio | 13.09% |
Buyback Yield | 5.28% |
Shareholder Yield | 6.14% |
Earnings Yield | 6.96% |
FCF Yield | 6.82% |
Analyst Forecast
The average price target for HCA Healthcare is $376.20, which is 11.97% higher than the current price. The consensus rating is "Buy".
Price Target | $376.20 |
Price Target Difference | 11.97% |
Analyst Consensus | Buy |
Analyst Count | 17 |
Revenue Growth Forecast (5Y) | 5.97% |
EPS Growth Forecast (5Y) | 12.30% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.64 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.64 |
Piotroski F-Score | 6 |